Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Demise of the Inpatient Rheumatology Unit

Ruth Jessen Hickman, MD  |  Issue: July 2018  |  July 19, 2018

Partly because treatment options were so limited for rheumatic diseases, rehabilitation via hospitalization was seen as a key mode of management. Early studies of these units documented that, on average, patients with rheumatoid arthritis were hospitalized for two to three months, with some staying a year or longer.3

Dr. Matteson notes that on the whole, the shift reflects a change for the best. People do not have to stay in the hospital as much, & he believes the model generally fosters good patient outcomes.

Inpatient Rheumatic Disease Units

Jonathan Scott Coblyn, MD, is the director of clinical rheumatology at Brigham and Women’s Hospital, Boston, and an associate professor at Harvard Medical School. He completed his fellowship in the late 1970s at Robert Breck Brigham Hospital (RBBH; which became Brigham and Women’s Hospital in 1980, after merging with the Boston Hospital for Women and the Peter Bent Brigham Hospital). He notes that, at the time, RBBH was filled with people with rheumatic disease or people who were there for orthopedic surgery. “There were no hospitalists at that time, so we would all take our turn, like you do in a general medical service, but it would be on the inpatient rheumatology service. We had hospital-employed doctors, and we had private practice doctors who admitted there as well.”

“When I was a fellow,” Dr. Coblyn says, “the indication for someone with rheumatoid arthritis to be admitted to the hospital was new-onset rheumatoid arthritis or a flare of their rheumatoid arthritis. That’s inconceivable now. People were admitted, and they stayed in for almost two weeks—three weeks or more. We gave them aspirin and paraffin wax and Hubbard tubs and physical therapy and started them on gold shots. The service was covered by housestaff.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The patients would often have quite severe symptoms. As Dr. Coblyn remembers, “You would see people who would come in—they would have both hips, both knees, maybe their neck fused, and they’d be in there for months and see the rheumatologists, orthopedists and therapists. It is now a totally different patient population and almost a different disease than it was then.”

When Dr. Matteson came to the Mayo Clinic in the late 1980s, it had an in­patient rheumatology service, as well as a consulting service that went to different hospitals. “This was for patients with rheumatic diseases—for example, rheuma­toid arthritis flares or lupus flares—and we would have them hospitalized on the rheumatology service. And in fact there were three inpatient services, because frankly we didn’t have very effective treatments. Patients would be in the hospital for extended periods of time for physical therapy, to receive steroids, maybe to get started on a drug like sulfasalazine or Plaquenil.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Practice Support Tagged with:inpatientoutpatient

Related Articles

    Rheumatologist Dr. Jonathan Coblyn Releases Stress by Fishing

    July 12, 2016

    Jonathan Coblyn, MD, was around 10 years old the first time his father took him fishing in April to Great South Bay, the largest shallow saltwater bay in New York. It was so cold that he remembers scraping frost off the lines that tied the family’s 26-foot motorboat to the pier. Dr. Coblyn, clinical chief…

    Tips for Handling Less Common Rheumatoid Arthritis-Related Disorders

    February 16, 2017

    WASHINGTON, D.C.—As treatments for rheumatoid arthritis (RA) improve, some related conditions that used to be common in patients with RA are not seen very often anymore, but they still exist and physicians need to know how to identify them. Speaking to attendees at the ACR/ARHP Annual Meeting talk titled Rheumatoid Arthritis—A Case-Based Approach to Selected…

    Rheum After 5: Dr. Eric Matteson Writes Rheumatic Disease History

    August 12, 2020

    Over the past 20 years, Eric L. Matteson, MD, MPH, emeritus chair, Division of Rheumatology, and emeritus professor of medicine at the Mayo Clinic College of Medicine and Science, Rochester, Minn., as well as a past president of the Rheumatology Research Foundation, has authored or co-authored six books about the history of rheumatic disease and…

    Kussmaul, Meier & Polyarteritis Nodosa

    April 26, 2018

    In 1866, Adolf Kussmaul, an internist, and Rudolf Maier, a pathologist, published the classic characterization of what eventually became known as polyarteritis nodosa.1 It was the first scientific clinical characterization of a noninfectious vasculitis. As such, it became a paradigmatic point of contrast to other types of vasculitides that were later described. Their description also…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences